|
Scientists have identified key compounds that stimulate stem cell growth in the brain, which may one day lead to restored function for people affected by Parkinson’s disease, strokes, multiple sclerosis, and a wide range of neurological disorders, it was announced September 1.
The findings, published in the September 2006 issue of The FASEB Journal, provide important clues as to which compounds may be responsible for causing key brain cells, neurons, to regenerate and ultimately restore brain function.
The research study focused on two compounds: LTB4 (leukotriene B4) and LXA4 (lipoxin A4).
Both play a role in inflammation and are regulators of proliferation of several cell types.
When stem cells isolated from the brains of mouse embryos were exposed to LTB4 they proliferated and differentiated, giving rise to additional stem cells and to differentiated neurons with limited or absent capacity to divide.
When exposed to LXA4, these cells experienced decreased growth and apoptosis.
“This study opens doors to new therapeutic approaches for a wide range neurological disorders and injuries that were once considered incurable,” said Gerald Weissmann, M.D., editor-in-chief of the journal.
The study also provided so insight into the cellular and molecular mechanisms involved when LTB4 stimulates neuronal stem cells.
According to the study, cells generated as the result of LTB4 exposure had high levels of LTB4 receptors, whereas the level of LTB4 receptors was considerably lower in similar cells not generated by LTB4 stimulation. The investigators were further able to show that LTB4 up-regulated several molecules involved in cell cycling and growth, such as cyclins and epidermal growth factor receptor, and decreased those such as caspase 8 which play a role in apoptosis. LXA4 had the opposite effects.
...
Citation: (Article name, authors,
publication, DOI)
Article or Abstract: (link)
Contact: (link)
Start a free one-week trial
subscription to StemCellResearchNews.com to access
ALL premium
content on this Web site.
Read about research you won't hear about on the nightly news or
on Google.
Click here. (See below for information on why Premium Content is
really worth
it.)
Get the whole story: article citations, links
to further information, links to journal abstract pages, related
articles, researcher contact information, etc.
Or ...
Subscribe
to Stem Cell Lab World, Stem Cell Research News,
Stem Cell Business News for complete access PLUS biweekly
e-mail delivery of a PDF publication you can save on your
computer or print and store in a binder.
FAQ: Why do you charge to read Premium Content ($) articles?
For many years we have provided stem cell-related news and
analysis free of charge on this Web Site, supported by
advertising and subscription income. Unfortunately, in today’s
economy, advertising placements are at an all-time low. That has
forced us (and other publishers) to seek income elsewhere.
Hence, the subscription fees for premium content.
FAQ: What makes Premium Content articles worth the price?
There are seven key reasons:
1) You read about stem cell research you'll never hear about
in the general press, and you'll get the complete article, not just a snippet.
2) Important references are clickable links. (e.g., a
reference to a research institution
or researcher's lab site or more
information about a disease or disorder
are highlighted and clickable as Web links.)
3) Full citations are provided for all journal articles
so you can access the original research.
4) Links to article abstracts are provided.
5) Links to researcher e-mail addresses and lab Web sites
are provided whenever available.
6) Graphic images are provided when available.
7) Links to Related Articles in our database of more than
2,000 stem cell research articles.
Subscribe now!
Click here
to subscribe to a newsletter (including biweekly delivery of PDF
editions PLUS Web site Premium Content) or
click here to
subscribe to the Web site Premium Content only.
 |
